In a marketing exercise for Archlife.com.au an investment subscription newsletter they have given for free the linked article written mid-2020.
The writer is Claude Walker who has followed the company for years.
https://arichlife.com.au/the-case-for-alcidion-asx-alc/
Interesting in it he mentions $16m cash in the bank, where someone in a forum post just recently says it's now $12m.
I post this for your information and apologise if it's been posted before.
Personally, it's not a company for me. Selling a product into a public hospital is a daunting task, risky in an investment sense and a long time frame.
Mark